Oncology

 

 

 

Chemotherapy & Radiation therapy A Growing Trend of Diseases and Therapies

Prevalence of Cancer across the Globe…

•       In 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime.

National Onco-Nutrition Market Potential in India (2025)

·         Total Monthly Market Size: ₹40–60 crore

·         Annual Potential: ₹500–700 crore

·         Top Contributing States:

·         Maharashtra, Telangana, Delhi NCR, UP

·         Ahmedabad, Karnataka

The India Clinical Nutrition for Cancer Care Market was valued at $102.4 million in 2023 and is projected to grow at a CAGR of 8.04% from 2023 to 2030, reaching $175.9 million by 2030.

Challenges during Chemo and Radiation therapy:

·         Weight loss

·          Fatigue

·          Muscle wasting

·          Oxidative stress

·          Not taking the complete dose of nutrition

Common Nutritional Challenges in Cancer Patients

·         Appetite Loss

·         Patients often experience reduced appetite, leading to inadequate calorie intake, which can affect treatment outcomes and recovery.

·         Taste Changes

·         Cancer treatments can alter taste perception, making certain foods unappealing.

Today’s medical science believes that adequate Nutrition helps fight cancer and improve the Quality of life for patients.

Why do Cancer patients require Specialized Nutrition?

• 80-90% of cancer patients suffer from malnutrition
•  Malnutrition impacts on
•  Treatment
•  Tolerance
•  Outcomes
•  Quality of life

Unique Combination of protein

Whey Protein Hydrolysate + Isolate

·          High biological value Whey Protein (WPH+WPI)

·          Rapid Absorption

·          PDCAAS=1

·          Improves Immune support

Unique Ingredients

Selenium

·         Plays a significant role in diminishing the risk of cancer.

·         Additionally, selenium exhibits properties that inhibit the invasive and metastatic capabilities of tumours.

·         Selenium also finds application in the support treatment of cancer through radiation therapy and chemotherapy protocols.

·         Selenium has a well-established history as a potent agent in the prevention of cancer.

·         It’s a potent antioxidant and reduce oxidative stress.

L- Glutamine

·         Glutamine antagonism, aiming to disrupt tumor growth by targeting Critical metabolic pathways.

·         Glutamine supplementation supports immune function

·         Improves gut integrity

·         Improves patient well-being.

·         Moreover, recent studies highlighted its contributions to epigenetic regulation within cancer cells and its potential to bolster anti-cancer immune functions.

·         Glutamine, as a key player in cancer metabolism, holds significant promise as a target for therapeutic intervention.

R-Nucleotide

·         Reduce cancer progression.

·         Targeting nucleotide metabolism enhance immunotherapy during cancer treatment.

·         It helps to immune cells metabolism of nucleotides to overcome the challenges they face during abnormal growth and proliferation.

Docosahexaenoic acid

·         DHA is safe and can greatly improve the anticancer properties of anticancer drugs and improve drug efficacy.

·         DHA, a natural anticancer compound, alters the contents of exosomes secreted by breast cancer cells.

Eicosapentaenoic acid (EPA)

·         EPA enhances the sensitivity of osteosarcoma to cisplatin

·         The combination of EPA and DHA represents a promising and encouraging anti-tumor strategy.

·         These findings provide valuable evidence for the clinical translation of EPA as an adjunctive therapy in osteosarcoma treatment.

BCAA’s

·         BCAA possesses significant significance in the occurrence and progression of tumors.

·         BCAA plays a complex role in tumor metabolism, with dietary BCAA exerting both promoting and inhibiting effects on tumors.

·         BCAA supplementation inhibits tumor development, potentially through mechanisms like triggering cell-cycle arrest or enhancing immune-mediated anti-tumor responses.

Omega-3 Fatty Acids

·         Omega-3 supplementation is widely employed in cancer patients, mainly as an adjunctive treatment.

·         Omega-3 PUFAs promote favourable effects in cancer-related complications, such as pain, depression, and cachexia-anorexia syndrome.

Bovine Colostrum

·         The beneficial properties of LF and other bioactive BC components are mediated by their well-documented physiologic actions, such as:

§  promotion of T- and B-cell maturation,

·         Effect on hypothalamus–pituitary–adrenal (HPA) axis function

·         Regulation of iron metabolism

·         Growth promotion of beneficial intestinal mucosal membranes.

 

·         The presented review allows BC to be a natural, safe, and valuable product that can be used as an adjunctive therapy (supportive care) for the treatment of cancer.

Dilution of Maxotin Onco

·         Maximum number of patients with Cancer unable to tolerate a high amount of liquid.

·          Maxotin Onco is scientifically designed to overcome the fluid burden in the body.

·          Maxotin Onco is a fluid-restricted scientific feed formula due to its high biological value protein.

·          Mix 2 scoops=30g in 90ml of Milk or Water

Palatability is the Major concern in Onco-patients

•       Flavor plays an important role in Onco Nutrition

•       Available in the most appreciated Flavor